GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Change In Payables And Accrued Expense

RBC Bioscience (ROCO:6848) Change In Payables And Accrued Expense : NT$0.0 Mil (TTM As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is RBC Bioscience Change In Payables And Accrued Expense?

RBC Bioscience's Change In Payables And Accrued Expense for the quarter that ended in Dec. 2023 was NT$0.0 Mil. It means RBC Bioscience's Accounts Payable & Accrued Expense stayed the same from Jun. 2023 to Dec. 2023 .

RBC Bioscience's Change In Payables And Accrued Expense for the fiscal year that ended in Dec. 2023 was NT$0.0 Mil. It means RBC Bioscience's Accounts Payable & Accrued Expense stayed the same from Dec. 2022 to Dec. 2023 .

RBC Bioscience Change In Payables And Accrued Expense Historical Data

The historical data trend for RBC Bioscience's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RBC Bioscience Change In Payables And Accrued Expense Chart

RBC Bioscience Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Payables And Accrued Expense
Get a 7-Day Free Trial - - - - -

RBC Bioscience Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Change In Payables And Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

RBC Bioscience Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was NT$0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Bioscience Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of RBC Bioscience's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

RBC Bioscience (ROCO:6848) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RBC Bioscience Corp (ROCO:6848) » Definitions » Change In Payables And Accrued Expense
Comparable Companies
ROCO:4197 ROCO:6744 ROCO:6864 ROCO:6662 ROCO:4131 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX SZSE:300122 BGNE ALNY OCSE:GMAB BMRN
Traded in Other Exchanges
N/A
Address
Lane 235, Baoqiao Road, 3rd Floor, No. 132, New Taipei City, TWN, 23145
Website
https://www.rbcbioscience.com
RBC Bioscience Corp is a bio sciences company. Its products include Real Genomics, MagCore Automated Nucleic Acid Extractor, and MagCore Nucleic Acid Extraction KIT.

RBC Bioscience (ROCO:6848) Headlines

No Headlines